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eDepartment of Nephrology, Memorial University of Newfoundland, Health Sciences Centre, St John’s, Newfoundland, CanadaAbstractObjective: To document the prevalence and pattern of risk factors for contrast-induced nephrotoxicity (CIN) in an outpatient population
referred for contrast-enhanced computed tomography (CT) (CECT) studies.
Methods: Over a 4-month period, 3261 patients presenting for CT studies were asked to consent to a survey of CIN risk factors. Among these
patients, 957 were outpatients who received contrast material before the CT study. Demographic information and available serum creatinine
(SCr) data for these patients were extracted from medical records and then analysed. A telephone questionnaire to document risk factors was
administered to 200 of these patients, who were outpatients not referred from the emergency department or on dialysis.
Results: Among the 200 surveyed patients, 69% reported risk factors for CIN or for kidney function impairment (low estimated glomerular
filtration rate [eGFR]) at baseline. Among these patients, 43% reported multiple (2 or more) risk factors. Patients older than the mean age of
53 years had a higher incidence of having multiple risk factors when compared with those younger than this age. Patients with kidney
function impairment at baseline had a higher incidence of having multiple risk factors when compared with those with normal kidney
function. Among the patients with no SCr investigation in the 3 months preceding a CECT, 64% had multiple risk factors. In the study
population of 957 outpatients undergoing CECT, 52% had SCr measurements within 3 months before the study. An eGFR of less than
60 mL/min/1.73 m2 was found in 17% of the study population, and, in 0.6%, the eGFR was less than 30 mL/min/1.73 m2.
Conclusion: In an ambulatory outpatient population, many patients presenting for outpatient CECT studies will have risk factors for CIN or
for kidney function impairment (low eGFR) at baseline. Kidney function assessment, therefore, is indicated in this patient population before
CECT.ResumeObjectif : Documenter la prevalence des facteurs de risque de nephrotoxicite des produits de contraste chez un groupe de patients non
hospitalises devant subir une tomographie par ordinateur avec injection de contraste.
Methodes : Sur une periode de quatre mois, on a demande a 3261 patients devant subir un examen par CT Scanner s’ils consentaient a
participer a une enque^te sur les facteurs de risque de nephrotoxicite des produits de contraste. De ce nombre, 957 etaient des patients non
hospitalises a qui l’on a injecte un produit de contraste avant l’examen de CT Scanner. Les renseignements demographiques sur ces patients
et les donnees disponibles sur leur taux de creatinine serique (CrS) ont ete extraits des dossiers medicaux, puis analyses. Deux cents de ces
patients, qui n’etaient hospitalises, mais qui ne provenaient pas du service d’urgence et qui n’etaient pas sous dialyse, ont repondu a un
questionnaire telephonique sur les facteurs de risque.
Resultats : Sur les 200 patients ayant repondu au questionnaire telephonique, 69% presentaient des facteurs de risque de nephrotoxicite des
produits de contraste ou de deterioration de la fonction renale (faible debit de filtration glomerulaire estime [DFGe]). De ce nombre, 43%* Address for correspondence: Dipinder Keer, MD, MS, BBA, Department
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178 M. Carstensen et al. / Canadian Association of Radiologists Journal 63 (2012) 177e182affichaient plusieurs facteurs de risque (deux ou plus). Les patients dont l’a^ge depassait l’a^ge moyen de 53 ans etaient plus nombreux a
presenter plusieurs facteurs de risque que les patients de moins de 53 ans. Les patients qui souffraient deja d’une insuffisance renale etaient plus
nombreux a presenter plusieurs facteurs de risque que ceux dont la fonction renale etait intacte. Chez les patients n’ayant pas subi d’analyse du
taux de creatinine serique (CrS) dans les trois mois precedant l’examen par CT Scanner avec injection de contraste, 64% presentaient plusieurs
facteurs de risque. Au sein du groupe de 957 patients non hospitalises devant subir un examen par CT Scanner avec injection de contraste
etudie, 52% avaient subi une analyse du taux de CrS dans les trois mois precedant l’etude. Un DFGe de moins de 60 ml/min/1,73 m2 a ete
decouvert chez 17% de la population etudiee. Chez 0,6% de cette population, le DFGe etait de moins de 30 ml/min/1,73 m2.
Conclusion : Au sein d’un groupe de patients non hospitalises, de nombreuses personnes devant se presenter pour subir un examen par CT
Scanner avec injection de contraste presentent des facteurs de risque de nephrotoxicite des produits de contraste ou de deterioration de la
fonction renale (faible DFGe). Il est donc indique d’evaluer la fonction renale de ces patients avant de leur faire subir un examen avec
injection de contraste.
 2012 Canadian Association of Radiologists. All rights reserved.
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Risk factors for contrast-induced nephrotoxicity in surveyed samplea
Risk factor Incidence (%)
Nephrotoxic medications 71 (36)
Diuretics 32 (45)
Nonsteroidal anti-inflammatory drugs 19 (27)
Antibiotics 15 (21)
Immunosuppressants 10 (14)
Chemotherapeutics 8 (11)
Hypertension 59 (30)
Cardiovascular/peripheral vascular disease 44 (22)
Chemotherapy (current and previous) 42 (21)
Age 70 y or older 26 (13)
Diabetes 20 (10)
Liver disease 13 (7)
Renal disease 11 (6)
Renal surgery 9 (5)
CHF 1 (1)
Transplant 0 (0)
HIV 0 (0)
CHF ¼ congestive heart failure; HIV ¼ human immunodeficiency virus.
aFrom Ref. 5.Introduction
Acute kidney injury secondary to iodated contrast mate-
rial (CM), commonly referred to as contrast-induced neph-
rotoxicity (CIN), has been a phenomenon of increased
interest in recent years for a variety of reasons. It has been
reported to be a major cause of acute kidney injury. CIN has
a predictable time course and is amenable to timely
preventative measures [1]. Ever-increasing utility of contrast-
enhanced computed tomography (CT) (CECT) in diagnostic
imaging continues to motivate the re-evaluation of the risk of
CIN among those referred for CECT.
CIN has been defined as a rapid deterioration of renal
function after parenteral CM administration. This renal
function deterioration has been variably defined as
a minimum increase from baseline serum creatinine (SCr)
values of 25%-50% or an absolute increase in SCr of 0.5-
1.0 mg/dL [2,3]. The incidence of CIN has been reported to
range from less than 1% to more than 30%. This wide
variation in incidence is attributed to factors that include the
following: a lack of consensus in definitions; assessments
based on SCr levels rather than more direct measures of
kidney function; differing patient populations, such as
inpatients vs outpatients; wide variability in CM doses;
variation in the completeness or timing of patient follow-up;
and variation in the patient’s hydration state [2].
There has been controversy about whether there is much
risk for CIN after intravenous (IV) contrast compared with
the intra-arterial route, which has been much more exten-
sively analysed [4]. If CIN occurs after intravenous contrast
administration, then it tends to be in people with risk factors.
Multiple risk factors for developing CIN have been cited by
the Canadian Association of Radiologists (Table 1) and
patients’ risk increases exponentially with the number of risk
factors present [5,6]. These risk factors may be considered as
2 likely overlapping sets, one that includes risks to identify
those who might have kidney function impairment (low
eGFR) at baseline and who should have this measured, and
another set of factors with general significance for CIN.
Although the risk factors were selected from the literature by
the Canadian Association of Radiologists as being associatedwith CIN, they include many factors that are risks for low
eGFR, and the risk for CIN may be in part caused by this
mechanism rather than independently from the risk factor
itself. In reality. the true risk with modern contrast agents
associated with the list of risk factors is probably low and is
not well documented for intravenous contrast [4].
For logistic reasons at least, CIN prevention efforts should
be focused on those at higher risk. In designing an approach
to prevention, especially for the outpatient population, it is
necessary to understand the risk profile of the population to
focus preventative efforts on those with relevant risk factors.
It proves difficult in practice, however, to use knowledge of
these risk factors to evaluate the need of preventative
measures in a predictable, clinically useful way. Although
the measurement of eGFR provides a useful metric, it
requires blood collection and testing, which proves to be
a logistical challenge in some patients, such as those being
examined in an outpatient setting. A review of risk factors for
the development of CIN could be used to identify those who
may need eGFR measurement and subsequently to evaluate
the need for preventative measures. A number of recent
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practices [7e12]. We designed the following study to
examine the risk profile of an outpatient population having
CT because they may not have strict risk screening done,
especially kidney function tests.
Methods
Between August and December 2006, 3261 patients
underwent CT studies in the radiology department at our
facility (a tertiary referral centre) (Figure 1).Electronicmedical
recordswere reviewed to extract demographic information (age
and sex) as well as available SCr values, to a maximum of 3
results before the studies. An estimated glomerular filtration
rate (eGFR)was calculated for all available SCr values by using
the modification of diet in renal disease formula [13]. These
patientswere providedwith awritten invitation to participate in
the survey portion of this study. A total of 377 patients returned
signed consent forms. Among these patients, 159 were
excluded (outpatients receiving non-contrast-enhanced CT
studies, patients referred through the emergency department,
inpatients, and patients on chronic hemodialysis), because they
might have competing risk for acute kidney injury because of
causes unrelated to contrast administration. Patients on dialysis
were excluded because creatinine levels are not a reflection of
kidney function in such a population.
The remaining 218 patients available for the survey were
self-selected by virtue of consenting from within the pop-
ulation that met the study criteria. These patients were
sequentially contacted after their imaging procedure until
a survey sample of 200 patients was achieved; 200 was
chosen as a sample size for the survey as this would yield
a 95% confidence interval width of 7% on either side around
an estimated 50% prevalence of risk factors. The patients
were contacted by telephone and administered a general
health questionnaire regarding risk factors for CIN (Table 1).
This study received ethics approval from the human inves-
tigation committee.
Results
During the 4-month period, 1707 patients undergoing CT
studies were outpatients. Among these, 957 patients (56%)Figure 1. Study method flow chart. CECT ¼ contrast-enhanced comhad CM administered before the CECT study. In this study
population, the mean age was 54 years, and 56% were
women. These characteristics were similar in the surveyed
sample of 200 of these patients, in whom the mean age was
53 years, and 59% were women (Table 2).
Among the 200 surveyed patients, nephrotoxic medica-
tion was the most commonly reported risk factor for CIN
(36%), with nonsteroidal anti-inflammatory drugs and
diuretics being the most commonly reported medications.
Hypertension was identified by 30% of patients, with
cardiovascular or peripheral vascular disease identified by
22% of patients; 10% of these patients identified as being
diabetic. The prevalence of the remaining risk factors
assessed is detailed in Table 1. Multiple (2 or more) risk
factors for CIN were reported by 138 of the surveyed patients
(69%) (Figure 2). Among these patients, 68 (49%) had a SCr
investigation in the preceding 90 days and 39 (28%) had one
in the preceding 30 days. No risk factors were reported by 62
of the surveyed patients (31%). Among these patients, 22
(35%) had a SCr investigation in the preceding 90 days and
10 (16%) had one in the preceding 30 days (Table 3).
Multiple risk factors were present in 43% of patients (Figure
2). When the prevalence of CIN risk factors was analysed by
age, the patients older than the mean age of 53 years had
a higher incidence of having multiple risk factors when
compared with those younger than this age (Figure 3).
Patients with kidney function impairment at baseline (eGFR
of less than 60 mL/min/1.73 m2) had a higher incidence of
having multiple risk factors when compared with those with
normal kidney function at baseline (Figure 4).
In the study population of 957 outpatients undergoing
CECT studies, 76% had a SCr on file (Table 2), however,
only in 52% was the SCr value from within the 3 months
before CECT. Of the study population, 17% had kidney
function impairment at baseline (eGFR of <60 mL/min/1.73
m2) (Table 2); 0.6% of the study population had an eGFR of
less than 30 mL/min/1.73 m2, and all of these patients had
a SCr investigation on file in the preceding 90 days. No cases
of CIN were documented during the study, however, it was
not routine to reassess renal function after CECT at our
institution, even in the presence of risk factors. It, therefore,
is possible that some of these patients did subsequently
develop CIN that was not identified.puted tomography; N ¼ study population; n ¼ surveyed sample.
Table 2
Characteristics: study population and surveyed sample
Outpatient CECT studies
P valueaStudy population Surveyed sample
No. patients 957 200
Mean age, y 54 53 ns
Sex
Men 422 (44%) 82 (41%) ns
Women 535 (56%) 118 (59%) ns
Pre-CECT kidney function assessment status
Pre-CECT SCr available 727 (76%) 184 (92%) <.001
SCr within 90 d of CT 497 (52%) 90 (45%) .07
Kidney function assessment
eGFR > 60 605 (83%) 162 (88%) ns
30 < eGFR < 60 118 (16%) 22 (12%) ns
eGFR < 30 4 (<1%) 0 (0%) ns
CECT ¼ contract-enhanced computed tomography; eGFR ¼ estimated
glomerular filtration rate; ns ¼ non significance; SCr ¼ serum creatinine.
aAll tests were c2 other than mean age, which was t test; cutoff for ns, P <
.05.
Table 3
Pre-CECT kidney function assessment status among surveyed patients
Risk factors for CIN
Yes No
No. of patients (% of all surveyed patients) 138 (69%) 62 (31%)
Days between last SCr measurement and CECT
<90 68 (49%) 22 (35%)
<30 39 (28%) 10 (16%)
CECT ¼ contrast-enhanced computed tomography; CIN ¼ contrast-induced
nephrotoxicity; SCr ¼ serum creatinine.
180 M. Carstensen et al. / Canadian Association of Radiologists Journal 63 (2012) 177e182Discussion
A recent study by Mitchell et al [14] found the incidence
of CIN after CECT to be 11% in the outpatient setting. CIN
was associated in the study with an increased risk for severe
renal failure and death from renal failure. In populations that
have cardiac angiography, CIN has been associated with
other more clearly serious adverse health outcomes,
including major cardiovascular events, prolonged hospitali-
zation, and early death [4]. In reality, given the mild and
transient nature of acute kidney injury in most CIN cases, it
is the association with these later more momentous clinical
adverse events that drives current research in preventing
CIN. To the extent that CIN events may be causally related to
the later adverse outcomes, it is important to try to identify
effective preventive measures against CIN. In conducting
this study, we were interested in ambulatory patients rather
than those referred via the emergency department who
generally tend to be screened via kidney function tests as part
of their investigational workup. Ambulatory patients,
however, are more likely not to undergo such evaluation of
their kidney function before CECT. No other criteria wereFigure 2. Incidence of risk factors for contrast-induced nephrotoxicity (CIN)
in the study population.applied for patient selection other than being scheduled for
CECT.
The study by Mitchell et al [14] reported that 41% of
patients had none of the presumptive risk factors for CIN,
and 25% had 1 risk factor. Our study resulted in a lower
proportion (31%) of patients reporting none of the
presumptive risk factors but a comparable proportion (26%)
reporting 1 risk factor. These variations may be caused by the
more abbreviated list of risk factors assessed in the Mitchell
study [14]. A large proportion of patients in our study (43%)
had multiple risk factors for CIN. Several of the most
commonly encountered risk factors, including cardiovascular
disease, hypertension, and previous chemotherapy, are not
surprising. However, the most common risk factor encoun-
tered was recent nephrotoxic medication use, an easily
identifiable and modifiable risk factor. With proper history
taking, this risk factor can be effectively elucidated and
subsequently managed.
We relied on self-reporting of risk factors by the patients
interviewed. It is possible that the patients may have reported
having a condition that may not have been formally diag-
nosed. Nonetheless, as in routine clinical practice where we
trust our patients to provide a relatively accurate medical
history, we took the responses received from the patients as
part of this study as fact. We did not design this study to
evaluate the rate of CIN in our population. We would thus
not be able to comment if minor CINs occurred among the
patients or if serious cases may have presented to the hospital
after the procedure.
Our survey results show that, whereas some outpatients
presenting for CECTwill not have risk factors for CIN or forFigure 3. Incidence of risk factors for contrast-induced nephrotoxicity (CIN)
in the study population grouped by estimated glomerular filtration rate.
Figure 4. Incidence of risk factors for contrast-induced nephrotoxicity (CIN)
in the study population grouped by age. eGFR ¼ estimated glomerular
filtration rate.
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and thus may not need their kidney function tested, many
outpatients presenting forCECTwill have these risk factors, an
indication for kidney function assessment as suggested by
Thomsen and Morcos [15]. Not surprisingly, we found that
older patients had a higher incidence of having multiple risk
factors for CIN when compared with younger patients. We
chose the age of 53 years as a cutoff simply because it was the
mean age for the study population. Our data show that many
outpatients may not have kidney function measured before
CECT. A review of the risk factors of these patients for the
development of CIN, therefore, should be performed to iden-
tify those who may need eGFR measurement before CECT.
Despite the high incidence of designated risk factors for CIN in
our sampled population, it is unclear that these risk factors are
truly relevant in modern practice. More research with cohorts
gettingmodern contrast media IV, therefore, should be done to
develop a truly helpful risk prediction algorithm as has been
done by Mehran et al [16] for cardiac angiography.
We found that having kidney function impairment at
baseline increased a patient’s likelihood of having multiple
risk factors for CIN. Poor kidney function at baseline
measured by pre-CT SCr and eGFR evaluation is directly
related to one’s risk of developing CIN [17,18]. Although the
use of eGFR as a metric of kidney function has limitations,
the bias and error are less at a lower eGFR, which is where
the concern exists for CIN. As such, it seems prudent to
know the kidney function in patients who are already at
increased risk based on their medical history. Furthermore, as
previously stated, the list of risk factors for CIN also includes
many factors associated with the likelihood of having kidney
function impairment at baseline.
In our survey, only 49% of the patients with risk factors for
CIN also had a recent assessment of their renal function byway
of a SCr evaluation in the preceding 3 months, itself a fairly
long time window. The eGFR calculation was not routinely
done at our institution at that time. This has since changed, and
eGFR is now automatically reported along with all renalfunction testing reports. A much lower proportion (28%) had
a SCr on file in the 30 days preceding the CECT study. Sixty-
four percent of the patients with no recent SCr investigation (in
the preceding 3 months) had one or more CIN risk factors. We
also determined that having a CIN risk factor only moderately
increased one’s chance of having a recent SCr performed
compared with patients with no CIN risk factors, because 49%
of the patients with risk factors for CIN had a recent SCr on file
compared with 35% of the patients with no stated CIN risk
factors. It should be noted that participants in the survey were
more likely to have had SCr measured before CECT, but this
was not truewhen only SCr values within 90 days of the CECT
are considered. In addition, the distribution of eGFR before
CECT was similar when comparing those surveyed and the
study population as a whole. Thus, although there is a possi-
bility of selection bias rendering the survey sample nonrep-
resentative with regard to a risk-factor profile, the relative
comparability of the 2 populations in terms of assessment of
kidney function before CECT is reassuring.
Previous studies, such as that by Choyke et al [19], have
shown that the use of a questionnaire could reduce the number of
patients in whom SCr measurement was necessary before
imaging studies. Although our data might make a similar
implication, such an approach will still require eGFR to be
measured in a large fractionof thepopulation. Ideally, all patients
withCIN risk factorswho are scheduled for aCECT should have
a ‘‘recent’’ assessment of their renal function with a measured
SCr and eGFR calculation at least within the previous 3 months
before their study [5]. It may be sufficient, however, to imple-
ment a policy of screening history and selected eGFR in those at
risk for significant renal impairment. The evaluation of kidney
function before CECT via eGFR measurement was and still is
not routine at our centre as in many centres. Radiology depart-
ments need to decide if risk-factor assessment should trigger SCr
measurement before CECT in indicated patients.
Summary and Recommendations
Kidney function assessment via eGFR measurement as
a preventative measure against CIN requires blood collection
and testing, which proves to be a logistical challenge in some
patients, such as those being examined in an outpatient
setting. The survey conducted as part of this study reveals
that, whereas some outpatients presenting for CECT may not
have risk factors for CIN or for having kidney function
impairment (low eGFR) at baseline, many outpatients pre-
senting for CECT will have these risk factors, an indication
for kidney function assessment. Further research is needed to
develop evidence-based criteria to enable clinicians to
provide adequate access to CECT studies to patients with
suboptimal kidney function while appropriately managing
the risk of CIN in this population.
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